Multiple plastic stents versus covered metal stent for treatment of anastomotic biliary strictures after liver transplantation : a prospective, randomized, multicenter trial

Näytä kaikki kuvailutiedot



Pysyväisosoite

http://hdl.handle.net/10138/298131

Lähdeviite

Tal , A O , Finkelmeier , F , Filmann , N , Kylänpää , L , Udd , M , Parzanese , I , Cantu , P , Dechene , A , Penndorf , V , Schnitzbauer , A , Friedrich-Rust , M , Zeuzem , S & Albert , J G 2017 , ' Multiple plastic stents versus covered metal stent for treatment of anastomotic biliary strictures after liver transplantation : a prospective, randomized, multicenter trial ' , Gastrointestinal Endoscopy , vol. 86 , no. 6 , pp. 1038-1045 . https://doi.org/10.1016/j.gie.2017.03.009

Julkaisun nimi: Multiple plastic stents versus covered metal stent for treatment of anastomotic biliary strictures after liver transplantation : a prospective, randomized, multicenter trial
Tekijä: Tal, Andrea Oliver; Finkelmeier, Fabian; Filmann, Natalie; Kylänpää, Leena; Udd, Marianne; Parzanese, Ilaria; Cantu, Paolo; Dechene, Alexander; Penndorf, Volker; Schnitzbauer, Andreas; Friedrich-Rust, Mireen; Zeuzem, Stefan; Albert, Joerg G.
Muu tekijä: University of Helsinki, Department of Surgery
University of Helsinki, Clinicum
Päiväys: 2017-12
Kieli: eng
Sivumäärä: 8
Kuuluu julkaisusarjaan: Gastrointestinal Endoscopy
ISSN: 0016-5107
URI: http://hdl.handle.net/10138/298131
Tiivistelmä: Background and Aims: Treatment of anastomotic biliary strictures (ABSs) after orthotopic liver transplantation by endoscopic insertion of multiple plastic stents (MPSs) is well established. The use of covered self-expandable metal stents (cSEMSs) for this indication is less investigated. Methods: In an open-label, multicenter, randomized trial, patients with confirmed ABSs were randomly assigned 1:1 to receive either an MPS or a cSEMS. The primary endpoint was the number of endoscopic interventions until ABS resolution. Secondary endpoints were frequency of adverse events, treatment success rates, and time to treatment success and recurrence of ABS during follow-up of at least 1 year. Results: Fifty-eight patients were included between 2012 and 2015, and 48 patients completed follow-up. Patients receiving MPS (n = 24) underwent a median of 4 (range, 3-12) endoscopic retrograde cholangiography examinations, whereas those in the cSEMS group (n = 24) underwent a median of 2 (range, 2-12) sessions until ABS resolution (P <.001). A median of 8 (range, 2-32) stents was used until ABS resolution within the MPS group and 1 (range, 1-24) in the cSEMS group (P <.0001). cSEMS migration occurred in 8 (33.3%) patients. Treatment duration did not differ significantly. Initial treatment success rates were high with 23 (95.8%) in the MPS group and 24 (100%) for cSEMSs (P = 1). Five (20.8%) patients in both groups showed stricture recurrence after a median follow-up of 500 days (range, 48-1317 days). Conclusions: cSEMSs for treatment of ABSs needed less endoscopic interventions to achieve similar efficacy as MPS and might become a new treatment standard. However, the optimal duration of cSEMS therapy and cost-efficacy have to be evaluated.
Avainsanat: ENDOSCOPIC TREATMENT
MANAGEMENT
THERAPY
OUTCOMES
COMPLICATIONS
STENOSIS
DISEASE
3126 Surgery, anesthesiology, intensive care, radiology
Tekijänoikeustiedot:


Tiedostot

Latausmäärä yhteensä: Ladataan...

Tiedosto(t) Koko Formaatti Näytä
1_s2.0_S001651071730189X_main.pdf 813.0KB PDF Avaa tiedosto

Viite kuuluu kokoelmiin:

Näytä kaikki kuvailutiedot